This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Discover effective wealth growth strategies for beginners that pave the way to financial success. Start learning and investing wisely now.
23,833 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Zillow Group’s stock rose about 5% in early trading after January housing starts jumped 7.2% to 1.49 million annualiz...
CoreWeave lands a major funding and strategic deals, reinforcing its AI GPU cloud niche, while investors weigh heavy ...
Rocket Lab climbs on Neutron milestones as investors weigh SpaceX IPO chatter. The move underscores growing appetite ...
A massive new funding request for Iran-related operations has financial markets and households weighing the longer-te...
A biotech stock winner has surged 72%, yet a disciplined stake trim suggests a cautious pause. Here’s how to read the...
Disney, McDonald’s, Microsoft, and Procter & Gamble now appear oversold despite solid earnings and durable consumer s...
FuboTV has faced a brutal stretch, yet new synergies from Disney and Hulu may set up a rebound in EBITDA and subscrib...
Apple’s measured AI approach contrasts with Microsoft’s aggressive spending, signaling a shift in investor bets as th...
Anduril CEO Brian Schimpf has quietly steered the defense-tech startup from desert days to a major defense contractor...
A new round of claims alleges harassment at Carta, the private equity software unicorn valued near $7.4 billion. As m...
Regulatory pressure around UnitedHealth shifts attention to two defensible, cash-generating stocks with strong divide...